biotechnology

Traders are cranking up their bets against biotech stocks

Wikimedia CommonsSee AlsoAviation tracking service: Germanwings co-pilot set autopilot to the lowest possible settingFed market gurus prep rate hike amid last-minute anxietiesWe just found out who the third American was on the crashed Germanwings flightNEW YORK (Reuters) – A 4 percent decline in biotechnology stocks on Wednesday sent the Nasdaq Composite Index to its largest one-day loss in nearly a […]

Is The Biotech Stock Correction A Buying Opportunity Or A Wake Up Call?

Disclosure: I own shares of AMGN and GILDBiotechnology stocks have been in a sharp correction this week. The iShares Nasdaq Biotechnology ETF dropped close to one-percent in early Thursday trade, following a 1.89% decline on Wednesday; and the SPDR S&P biotech ETF registered similar losses.Is the correction a buying opportunity or a wake up call?Both.On the one side, the correction […]

Biotech outlook dire as bull market loses leader

Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]

ETF Investing: Biotech stocks on pace to snap 8-day win streak as warnings abound

ShutterstockNEW YORK (MarketWatch)—Biotech stocks slumped Monday, with the largest biotech ETF down about 1.7% and on track to snap an eight-session winning streak.The slide comes as some market watchers warn that biotech shares have enjoyed a great run-up and could be due for a drop.“Biotech must be slaughtered” is how a post over at the iBankCoin blog puts it.How low […]

The Top 5 Biotech Stocks of 2015 — Average Gains So Far Over …

The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]

Are Large-Cap Biotech Stocks in a Bubble? – InvestorPlace

No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: ©iStock.com/AlexRathsAt first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]

Is Intercept The Next Biotech To Break Out?

View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]

2 Growing Biotech Stocks to Buy (ALXN, CSII) | InvestorPlace

The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]

Biotech Blowoff Beats Even Dot-Com Madness

Annual health tech fests like the JPMorgan Health Care Conference, Biotech Showcase, and One Med Forum came and went this year in San Francisco. The star performers in this sector no doubt have a lot to brag about. They will also have a lot of explaining to do when the biotech and health care sectors eventually crash.The NASDAQ Biotechnology Index […]

There Go the Biotechs as Generic Approval Rocks Amgen

By Ben LevisohnBiotech stocks like Gilead Sciences (GILD) and Amgen (AMGN) have been a great place to be for investors. Now, the approval of the first biosimilar in the U.S. is raising concerns that biotech profits will decline–and causing their stocks to tumble. Citigroup’s Andrew Baum and team explain why:
Bloomberg News

Approval of Sandoz’s Zarxio, with full extrapolation across indications and lack […]